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https://doi.org/10.1016/j.stemcr.2020.07.004SUMMARYIonizing radiation exposure results in acute and delayed bone marrow suppression. Treatment of mice with 16,16-dimethyl prosta-
glandin E2 (dmPGE2) prior to lethal ionizing radiation (IR) facilitates survival, but the cellular and molecular mechanisms are unclear.
In this study we show that dmPGE2 attenuates loss and enhances recovery of bone marrow cellularity, corresponding to a less severe he-
matopoietic stem cell nadir, and significantly preserves long-term repopulation capacity and progenitor cell function. Mechanistically,
dmPGE2 suppressed hematopoietic stem cell (HSC) proliferation through 24 h post IR, which correlated with fewer DNA double-strand
breaks and attenuation of apoptosis, mitochondrial compromise, oxidative stress, and senescence. RNA sequencing of HSCs at 1 h and
24 h post IR identified a predominant interference with IR-induced p53-downstream gene expression at 1 h, and confirmed the suppres-
sion of IR-induced cell-cycle genes at 24 h. These data identifymechanisms of dmPGE2 radioprotection and its potential role as amedical
countermeasure against radiation exposure.INTRODUCTION
Billions of new blood cells are required daily to maintain
homeostasis and respond to stressors such as infection,
bleeding, or cell damage. The hematopoietic system is
extremely sensitive to ionizing radiation (IR) (Till and
McCulloch, 1964), which results in dose-dependent bone
marrow suppression known as the hematopoietic acute ra-
diation syndrome (H-ARS), characterized by pancytopenia
and possible death from hemorrhage or infection (Dainiak
et al., 2003). These life-threatening effects result from dam-
age to DNA and other components of hematopoietic stem
cells (HSCs) and hematopoietic progenitor cells (HPCs)
causing cell death or functional compromise (Shao et al.,
2014).
Prostaglandin E2 is a pleiotropic lipidwith effects onmul-
tiple organ systems, including normal and stressed hema-
topoiesis (Hoggatt and Pelus, 2010; Pelus and Hoggatt,
2011). When administered prior to IR, E prostaglandins
including 16,16-dimethyl prostaglandin E2 (dmPGE2),
can improve survival (Steel et al., 1988; Walden et al.,
1987), reduce intestinal stem cell and crypt damage (Han-
son andAinsworth, 1985; Hanson and Thomas, 1983), pro-
tect spermatogenesis (van Buul et al., 1999), and prevent al-
opecia (Hanson et al., 1992). Protection of the multipotent
progenitor cell CFU-S (colony-forming unit—spleen) was358 Stem Cell Reports j Vol. 15 j 358–373 j August 11, 2020 j ª 2020 The A
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et al., 1987). More recently, we and others demonstrated
that dmPGE2 can mitigate the effects of lethal IR on hema-
topoiesis (Hoggatt et al., 2013b; Porter et al., 2013). How-
ever, mechanisms whereby PGE2 protects hematopoiesis
or mitigates IR-induced damage are unknown.
In this study, we performed phenotypic and functional
analyses of primitive hematopoietic cells from mice early
after lethal-dose IR, and utilized RNA sequencing (RNA-
seq) to identify critical pathways of IR-induced damage
and radioprotection triggered by dmPGE2 in HSCs.RESULTS
dmPGE2 Protects Hematopoiesis from Lethal IR
Using a model of H-ARS in which hematopoietic effects are
responsible for mortality (Plett et al., 2012), we confirmed
radioprotection by dmPGE2. Single administration of
dmPGE2 30 min prior to total body IR protected 100% of
mice from a lethal dose of 8.53 Gy (Figure 1A). Given the
single dose and short half-life of dmPGE2, we hypothesized
that its critical radioprotective effects are manifested early
after IR before the onset of morbidity and mortality
(day 10), and evaluated bone marrow cells at 1 h, 24 h,
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or vehicle (Figure 1B). IR produced a rapid and progressive
decline in total nucleated cells (TNCs) that extended
through 9 days post IR in the vehicle group, whereas
TNCs declined less rapidly and began to rebound by day
9 in dmPGE2-treated mice (Figure 1C).
Histology further illustrated attenuation of hematopoiet-
ic cell loss at 24 h and 72 h post IR by dmPGE2,
with marrow volume rebounding by 9 days to 70%
of total tissue volume compared with 5% in the vehicle
group (Figures 1D, S1A, and S1B). The marrow cavity of
vehicle-treated mice displayed adipocyte accumulation
throughout the time course and the presence of red blood
cell infiltration, which suggests potential loss of sinusoidal
integrity. In contrast, little or no adipocytes or red blood
cells outside sinusoids were apparent at any time point in
mice treated with dmPGE2 (Figures 1D and S1A). The num-
ber of endosteal-lining osteolineage cells was unchanged
(Figure S1C).Effects of IR and dmPGE2 on HSCs and HPCs
Standard flow-cytometric analysis of HSCs and HPCs be-
comes obscured post IR due to loss of surface c-Kit (Simon-
net et al., 2009). To determine a reliable gating strategy, we
subjected Fgd5 mice with HSC-specific green fluorescence
(Gazit et al., 2014) to IR to track hematopoietic marker
expression in HSCs (Figure S2). At steady state, HSCs are
defined within the lineage⁻, Sca-1⁺, c-Kit⁺ (LSK) population
by SLAM family markers as CD150⁺CD48⁻ (SLAM-LSK)
(Oguro et al., 2013). Green fluorescent HSCs were detect-
able 24 h and 72 h post IR with a progressive decline in sur-
face c-Kit and increased Sca-1 as described by Simonnet
et al. (2009). However, SLAM markers could isolate HSCs
to equivalent purity without c-Kit at steady state (Kiel
et al., 2005) and after IR (Figure S2). Thus, we adopted a
‘‘wide LSK’’ gating strategy to encompass c-Kitlow and Sca-
1high cells with SLAM gating to define phenotypic HSCs
(pHSCs) both pre-IR and post IR (Figure 1E).Figure 1. dmPGE2 Given Before Lethal IR Promotes Hematopoieti
dmPGE2 or vehicle was given 30 min prior to 8.53 Gy IR.
(A) Survival post IR; n = 20 mice, dmPGE2; n = 60 mice, vehicle.
(B) Time-course schema.
(C) TNC; n = 5–8 mice/group.
(D) Representative femur H&E histology; 1003; n = 3–5 mice/group
(E) Representative wide LSK and SLAM gating for pHSCs.
(F) Number of pHSCs/mouse; n = 4–8 mice/group.
(G) Mean fluorescence intensity (MFI) of c-Kit on pHSCs; n = 5–8 mic
(H) Repopulating activity at 16 weeks post transplant of marrow ce
chimerism (left) and trilineage contribution (right); ‘‘Trilineage Rec
lineages; n = 6–8 mice/group.
(I) CFCs/mouse; n = 4–8 mice/group in two experiments.
(J) CFCs/mouse of survivors at day 35 post IR; n = 4–8 mice/group.
*p < 0.05, yp < 0.05 versus NI. See also Figures S1–S3. Data are mean
360 Stem Cell Reports j Vol. 15 j 358–373 j August 11, 2020dmPGE2 substantially delayed pHSC depletion at 24 h
and retained higher pHSC numbers at all time points (Fig-
ure 1F). Interestingly, c-Kit loss was attenuated at 24 h and
reversed by day 9 among total lineage⁻ cells (Figure 1E, top
panels) as well as on pHSCs (Figure 1G). Notably, while
TNCs were only modestly higher with dmPGE2 at 24 h
and reached a nadir equivalent to vehicle at 72 h (Fig-
ure 1C), pHSCs were particularly preserved at these time
points and increased in frequency among TNCs (Figures
S3A and S3B). In contrast, CD150⁻CD48⁺ cells (Figure S3A),
representing HPCs within the classical LSK gate (Oguro
et al., 2013) but not fully defined post IR, reflected the
mild TNC protection at 24 h and 72 h (Figure S3C) with
no change in frequency (Figure S3D). Frequency did
change at 9 days in the vehicle group due tomore dramatic
loss of other cell types, and was normalized in dmPGE2-
treated mice (Figures S3C and S3D).
Since phenotype does not always predict function (Chen
et al., 2019), we evaluated long-term HSCs by competitive
transplantation. Marrow from vehicle-treated mice 1 h
post IR (where no reduction in pHSCs was observed) or
24 h post IR (when pHSCs were clearly reduced) were essen-
tially unable to contribute to hematopoiesis by 16 weeks
post transplant (Figure 1H). In contrast, marrow from
dmPGE2-treated mice contributed significantly to long-
term trilineage reconstitution when harvested either 1 h
or 24 h post IR. Furthermore, HPC colony-forming cells
(CFCs) were significantly higher in mice that received
dmPGE2 comparedwith vehicle at all time points (Figure 1I)
and after recovery of survivors (Figure 1J). These findings
indicate that dmPGE2 given prior to exposure significantly
protects HSCs and HPCs from the effects of lethal IR.dmPGE2 Attenuates IR-Induced HSC Cycling and DNA
Damage
Wenext investigated potentialmechanisms responsible for
the strong radioprotective effect of dmPGE2 on HSCc Recovery
in two experiments; scale bars, 50 mm.
e/group.
lls from mice 1 h (top) and 24 h (bottom) post IR, showing total





Figure 2. dmPGE2 Attenuates Cycling and DNA Damage in pHSCs Post IR
(A) Representative Ki67/DAPI gating and analysis of pHSCs in G0 or S/G2/M at 1 h and 24 h post IR; n = 6 mice/group; *p < 0.05,
yp < 0.05
versus NI.
(B) (Top left) Gating of lymphoid (LP) and myeloid (MP) progenitors along with LSK. (Bottom left) Representative pyronin Y/Hoechst
gating. (Right) Cell cycle in non-IR populations post PGE. n = 6 mice/group/time point; vehicle (Veh) values from each time point were
used for normalization and combined (n = 18); *p < 0.05 versus Veh; #p < 0.1 versus Veh.
(legend continued on next page)
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number and function.While HPC protection is also impor-
tant, loss of c-Kit restricted flow-cytometric studies post IR
to the validated pHSC gate. Cell-cycle quiescence is a hall-
mark of HSCs, and restriction of cycling is essential to pre-
vent HSC depletion and maintain hematopoiesis (Cheng
et al., 2000). While hematopoietic stress stimulates HSC
proliferation to support emergency hematopoiesis (Pas-
segue et al., 2005), replication with unrepaired IR-induced
DNA lesions can cause additional high levels of DNA dou-
ble-strand breaks (DSBs) (Staszewski et al., 2008). We there-
fore examined HSC cell-cycle dynamics and DNA damage
signaling. In vehicle-treatedmice, the percentage of pHSCs
in S/G2/M phase more than tripled from non-IR levels by
24 h post IR, whereas pretreatment with dmPGE2 resulted
in significant preservation of the quiescent pHSC pool (Fig-
ure 2A). To test whether dmPGE2 inhibits cycling indepen-
dently of the irradiated environment, we investigated the
effect of dmPGE2 alone on cycle status over time in the
non-IR setting. This also allowed analysis of populations
enriched for myeloid progenitors (MPs) and lymphoid pro-
genitors (LPs) without loss of c-Kit (Figure 2B, left). In non-
irradiated mice, dmPGE2 suppressed cycling of classically
gated SLAM-LSK HSCs, as well as total LSK, MPs, and LPs
below homeostatic levels for at least 24 h, with a subse-
quent surge in cycling above steady state by 48 h most
likely representing a rebound effect (Figure 2B). Together,
these data suggest that cell-cycle suppression by dmPGE2
counteracts IR-induced HSC, and possibly HPC, prolifera-
tion during the first critical day following genotoxic insult.
To evaluate whether early suppression of HSC cell cycle
correlates with less DNA damage and repair, we analyzed
DNA damage response factors. Phosphorylation of ataxia
telangiectasia mutated (p-ATM), one of the first events in
response to DNA damage, was increased in HSCs by 1 h
post IR and remained elevated through 9 days in vehicle-
and dmPGE2-treated mice (Figure S3E). While p-ATM qual-
itatively marks DNA damage, its target histone subunit
H2AX is a quantitative marker for DSB sites (Mariotti
et al., 2013). Phosphorylated H2AX (gH2AX) increased
considerably between 1 h and 24 h post IR in HSCs from
the vehicle group, while significantly less was detected in
HSCs from the dmPGE2 group (Figure 2C). Foci of gH2AX
in each groupwere further visualized at 24 h by imaging cy-
tometry, recapitulating this pattern (Figure 2D). Although
gH2AX can increase during DNA replication in certain
cell types, the histogram inset (Figure 2C) and pHSC images
(Figure S3F) show high gH2AX in virtually all pHSCs of the(C) MFI of g-H2AX in pHSCs. Inset: representative histograms at 24 h
(D) Representative pHSCs by imaging cytometry for g-H2AX at 24 h p
(E) MFI of ku70 and ku80 in pHSCs at 24 h post IR. n = 6 mice/IR gro
See also Figure S3. Data are mean ± SEM.
362 Stem Cell Reports j Vol. 15 j 358–373 j August 11, 202024-h vehicle group and not just the27% shown to be in S/
G2/M (Figure 2A). gH2AX levels decreased by 72 h, remain-
ing higher than non-IR levels in HSCs from vehicle-treated
mice, but returning to basal levels in dmPGE2-treatedmice.
Since dmPGE2 could be increasing DNA repair rather than
attenuating DNA damage, we evaluated DNA-repair en-
zymes Ku70 and Ku80 of the non-homologous end-joining
(NHEJ) pathway, the main DSB repair mechanism in HSCs
(Mohrin et al., 2010). Both enzymes were significantly
increased in HSCs from the vehicle group at 24 h, consis-
tent with increased DNA damage requiring increased
DNA repair, and were significantly lower in HSCs from
the dmPGE2 group (Figure 2E), suggesting that dmPGE2 is
not increasing repair but attenuating the accumulation of
DNA damage. These data support a potential mechanism
whereby dmPGE2 attenuates further DNA damage in
HSCs by preventing cell-cycle entry too early after exposure
to lethal IR.
IR-Related Sequelae Are Attenuated in HSCs by
dmPGE2
Since dmPGE2 attenuated early cell-cycle entry and accu-
mulation of DNA damage in HSCs within 24 h post IR,
sequelae of IR damage were evaluated. Cleaved poly(ADP-
ribose) polymerase (PARP), a measure of apoptosis (Bou-
lares et al., 1999), was significantly elevated by 24 h post
IR inHSCs fromvehicle- but not dmPGE2-treatedmice (Fig-
ure 3A). Cleaved PARP increased in HSCs from both groups
at 72 h and 9 days, suggesting that dmPGE2 mediated a
delay in the onset of apoptosis in HSCs for at least 24 h.
While reactive oxygen species (ROS) generated directly
and immediately by IR contribute to initial DNA damage,
affected mitochondria can further increase ROS levels,
exacerbating cell damage (Ludin et al., 2014). dmPGE2 pre-
vented an increase in mitochondrial ROS in HSCs within
the first 24 h andmaintained significantly lower ROS levels
throughout the time course (Figure 3B). dmPGE2 also pre-
vented an IR-induced increase inHSCmitochondrialmem-
brane potential (Figure 3C). The transcriptional coactivator
PGC-1, which regulates mitochondrial biogenesis and ac-
tivity (St-Pierre et al., 2006), was significantly reduced in
HSCs from 24 h through 9 days post IR, but remained
significantly higher with dmPGE2 (Figure 3D). IR damage
also causes hematopoietic cell senescence (Botnick et al.,
1979; Chua et al., 2019; Himburg et al., 2017). The fraction
of HSCs expressing senescence-associated b-galactosidase
(SA-b-gal) (Figure 3E) and p16INK4A/cyclin-dependent. n = 6–8 mice/group; yp < 0.05 versus NI; *p < 0.05.
ost IR.
up, 3/NI; *p < 0.05.
kinase inhibitor 2A (Cdkn2a) (Figure 3F), increased in
vehicle-treated mice within 24 h of IR and continued to in-
crease through 9 days, but remained significantly lower in
dmPGE2-treated mice. Overall, dmPGE2 delayed apoptosis,
preservedmitochondrial homeostasis, attenuated ROS pro-
duction, and reduced senescence in HSCs post IR.
Molecular Networks in HSCs Affected by IR and
Modified by dmPGE2
The radioprotective effects of dmPGE2 on HSCs were man-
ifested early, preserving long-term repopulation capacity in
HSCs as early as 1 h after lethal IR. By 24 h post IR, dmPGE2
had attenuated loss of pHSC numbers, early pHSC cycling
and DNA damage, and other sequelae that compromise
HSC function. To understand molecular networks contrib-
uting to this early protection, we performed RNA-seq on
sorted pHSCs harvested 1 h and 24 h post IR from mice
receiving vehicle or dmPGE2 at 30 min. We utilized
Fgd5 mice to enhance HSC purity post IR, gating ZsGreen+
along with SLAM-LSK markers.
Multi-dimensional scaling (MDS) plots revealed strong
groupwise clustering (Figure 4A). By 1 h post IR, the
vehicle-treated non-IR (Veh-NI) and IR (Veh-IR) groups
clustered far apart, indicating substantial IR-specific
changes. In contrast, the dmPGE2-treated non-IR (PGE-
NI) and IR (PGE-IR) groups clustered close together, sug-
gesting that dmPGE2 dampens the impact of IR on HSC
gene transcription. Among genes increased by IR >2-fold
at 1 h and attenuated by dmPGE2 (false discovery rate
[FDR] < 0.05; total 155 genes), the most highly enriched
pathways were p53 signaling and apoptosis, followed
closely by tumor necrosis factor (TNF) and nuclear factor
kB (NF-kB) signaling pathways (Table 1). The genes
involved in the gene ontology (GO) term ‘‘apoptotic pro-
cess’’ in Table 1 (1 h post IR) are shown in heatmap form
in Figure 4B. Utilizing gene set enrichment analysis
(GSEA), apoptotic signaling was again highlighted in the
top scoring categories as both increased in HSCs by IR at
1 h, and attenuated with dmPGE2 (Table S1; Figures 4C
and 4D). NF-kB signaling scored highest by GSEA for
both an increase with IR and prevention by dmPGE2 (Table
S1), and these scores were driven largely by expression of
the NF-kB subunits themselves; multiple NF-kB subunits
and inhibitors were increased by IR and attenuated with
dmPGE2, and some inhibitors were specifically increased
by dmPGE2 (Figure 4E).
We utilized Ingenuity Pathway Analysis (IPA) to identify
potential upstream regulators involved in HSC IR damage
and protection. IPA predicted strong IR-induced activa-
tion of TNF, with a particularly high activation Z score
(+8.26, Figure 4F) based on the expression pattern of
194 downstream genes. Of these, 122 genes were signifi-
cantly different when dmPGE2 was given before IR,contributing to a predicted partial inhibition of TNF (Z
score of 2.21, Figures 4F and S4). Quantitation of
marrow TNFa indicated it was indeed increased within
1 h of IR but was not attenuated by dmPGE2 (Figure 4G),
suggesting that dmPGE2 may alter downstream HSC re-
sponses to TNFa rather than its production. Of the
TNFa receptors (TNFR1 and TNFR2), dmPGE2 increased
TNFR2 mRNA in HSCs within 1 h, regardless of IR expo-
sure, while TNFR1 mRNA was unaffected (Figure S5A).
Surface TNFR1 levels were lower at 1 h post IR, likely re-
flecting internalization, but interestingly remained high
in cells from mice that received dmPGE2 (Figure S5B).
Consistent with the TNFR2 mRNA pattern, surface
TNFR2 increased with dmPGE2 relative to cells from
both vehicle-treated IR and non-IR mice (Figure S5B).
This suggests that dmPGE2 may in part be modifying early
HSC responses to an IR-induced surge in marrow TNFa.
RELA (NF-kB p65) and TP53 (p53) were the next up-
stream regulators predicted to be most activated by 1 h
post IR and inhibited by dmPGE2 (Figure 4F). NF-kB is ama-
jor mediator of TNF signaling, and both regulators involve
downstream genes highly overlapping with TNF and each
other, suggesting interacting signaling networks (Figure 4F,
right). Of these top three regulators, p53 was most broadly
inhibited by dmPGE2 with a high negative Z score of4.30
comparable with the IR-induced activation Z score
of +5.44. Themajority of genes contributing to these scores
are known to be upregulated by p53, and were increased by
IR but remained significantly lower with dmPGE2 pretreat-
ment (Figure 4H). Some genes known to be downregulated
by p53 also contributed to these scores, becoming
decreased with IR but not with dmPGE2 pretreatment (Fig-
ure 4H, bottom cluster). The IR-upregulated genes down-
stream of p53 predominantly encode known apoptosis-
promoting molecules such as Aen (apoptosis-enhancing
nuclease), Bbc3 (BCL2 binding component 3), Cdkn1a (cy-
clin-dependent kinase inhibitor 1A, p21CIP1/WAF1, (p21)),
Eda2r (ectodysplasin A2 receptor), Ei24 (etoposide induced
2.4 mRNA), Fas (TNF receptor superfamily member 6),
Phlda3 (plecktrin homology like domain, family A, mem-
ber 3), Sesn2 (sestrin 2), and Trp53inp1 (tumor protein
p53-inducible nuclear protein 1). These also included nega-
tive feedback molecules such as Birc3 (baculoviral IAP
repeat-containing 3), Ccng1 (cyclin G1), Ddias (DNA dam-
age induced apoptosis suppressor), Mdm2 (transformed
mouse 3T3 cell double minute 2), and Ppm1d (protein
phosphatase 1D magnesium-dependent, delta isoform).
Relative expression levels of p53-signature genes were
confirmed by single-cell qRT-PCR in pHSCs purified from
wild-type mice 1 h post IR. Principal component analysis
(PCA) of single cells recapitulated the three-way groupwise
clustering (Figure 4I), and corresponding gene expression




Figure 3. Sequelae of IR Are Attenuated in pHSCs by dmPGE2
Apoptosis, mitochondrial activity, and senescence analyzed in pHSC-gated cells post IR.
(A) MFI of cleaved PARP; n = 5–6 mice/group.
(B) MFI of mitochondrial ROS; n = 5–9 mice/group.
(C) Mitochondrial membrane potential expressed as MFI ratio of TMRE to Mito Tracker Green; n = 4–5 mice/group.
(D) MFI of PGC-1; n = 4–8 mice/group.
(E and F) Percent positive for (E) SA-b-gal and (F) p16; n = 5–6 mice/group.
*p < 0.05, yp < 0.05 versus NI. Data are mean ± SEM.(Figure 4J). Upregulation of Fas, an apoptotic surface pro-
tein induced by p53 in response to DNA damage (Muller
et al., 1998), was confirmed at the protein level by flow cy-
tometry, roughly doubling on HSCs by 3 h post IR and
reaching >5-fold by 24 h (Figure 4K). In agreement with
themRNAfindings by RNA-seq (Figure 4H, ninth from bot-364 Stem Cell Reports j Vol. 15 j 358–373 j August 11, 2020tom), the increase in Fas surface protein was attenuated by
dmPGE2 (Figure 4L). Thus, dmPGE2 radioprotection inter-
feres with signaling networks downstream of TNF, NF-kB,
and p53 initiated almost immediately in HSCs by lethal
IR, predominantly blocking p53 activation and apoptotic
signaling by 1 h post IR.
Figure 4. dmPGE2 Blocks IR-Induced Gene Expression at 1 h and 24 h Post IR in HSCs
HSCs were sorted from dmPGE2- or vehicle-treated Fgd5 mice (ZsGr + pHSC) 1 h or 24 h post IR.
(A) RNA-seq MDS plots at 1 h and 24 h; n = 7–8 mice/group.
(legend continued on next page)
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Transcriptional Effects of dmPGE2 Alone inHSCs Prior
to IR
Pathways induced by dmPGE2 prior to IRmay be ‘‘priming’’
HSCs to respond differently upon exposure to IR, and could
represent protective factors. In addition, we explored
whether dmPGE2 affects HSCs by direct signaling, and
through which PGE2 receptor(s). dmPGE2 given up to 3 h
prior to lethal IR is still fully radioprotective (unpublished
data); thus, the non-IR dmPGE2 group at the 1 h time
point—corresponding to 1.5 h post dmPGE2 injection—
was analyzed for protective transcriptional activity. Of
note, the single most significant gene effect in HSCs by
dmPGE2 alone was a 17-fold increase in the cell-cycle inhib-
itor p21 (FDR = 5.63 1081), corresponding to the observed
cell-cycle suppressionwith dmPGE2 alone (Figure 2B). In to-
tal, 888 genes with >1.4-fold change and FDR < 0.05 were
utilized by IPA to predict the transcriptional regulators
most likely activated in HSCs by dmPGE2 alone (Table 2).
Atop the list was cyclic AMP (cAMP)-responsive element
binding protein 1 (CREB1), a known transcriptional medi-
ator of PGE2 signaling through EP2 and EP4 (Fujino et al.,
2005), supportingHSC-intrinsic dmPGE2 signaling through
one or both receptors.While EP2mRNAwas virtually unde-
tectable inHSCs by RNA-seq, EP4was highly expressed (Fig-
ure S6A). Also, of all PGE2 receptors, only EP4 mRNA levels
were affected by dmPGE2 (decreased) or IR (increased) (Fig-
ure S6B). Furthermore, based on known EP4 downstream
gene expression patterns, IPA predicted that EP4 activity
was decreased by IR (Z score2.34, p = 3.23 109) but pre-
served bydmPGE2 (Z score 2.48, p = 1.2310
10); EP4 down-
stream genes common to both Z scores and also affected by
dmPGE2 alone are shown in Figure S6C. This analysis sug-
gests that dmPGE2 acts directly on HSCs, likely through
EP4, and provides candidate protective transcriptional regu-
lators (Table 2) for further study.(B) Heatmap of genes associated with GO term ‘‘apoptotic process’’ (DA
*All genes FDR < 0.05 between indicated groups.
(C) GSEA plot for GO term ‘‘intrinsic apoptotic signaling pathway’’ in V
score.
(D) GSEA plot for GO term ‘‘intrinsic apoptotic signaling pathway by p
(E) Heatmap of NF-kB subunits and inhibitors at 1 h.
(F) Upstream regulators predicted by IPA as activated by IR and attenu
strength for activation (red) or inhibition (blue); p value, significanc
(G) TNFa in marrow supernatants 1 h post IR; n = 4–5 mice/group; *
(H) Heatmap of the most significant (*FDR < 0.001) TP53-regulated
(I and J) Single-cell qRT-PCR for genes from the TP53 signature in pHS
HSC. (J) Relative gene expression in a single HSC. All p < 0.05 for both V
with Dunn’s correction. LoD, limit of detection; Ct, threshold cycle.
(K) MFI of Fas on pHSCs; n = 3 mice/group; *p < 0.05 versus NI.
(L) MFI of Fas on pHSCs 24 h post IR; n = 3–5 mice/group; represent
(M) 24-h RNA-seq genes (*FDR < 0.05) associated with GO term ‘‘cell
(N and O) 24-h RNA-seq GSEA plots for (N) GO term ‘‘nuclear chromos
See also Figures S4–S6. Data are mean ± SEM.
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Effects in HSCs
Initial IR-induced TNF/NF-kB and p53 gene signatures were
short lived in HSCs, with most returning to basal levels at
24 hpost IR (Figure S4). At 24 h, the predominant transcrip-
tional effect of IR on surviving HSCswas an increase in cell-
cycle genes, whichwas significantly prevented by dmPGE2.
Genes increased by IR >2-fold at 24 h and attenuated with
dmPGE2 (both at FDR < 0.05; total 164 genes) were en-
riched for terms such as mitosis, cell division, mitotic nu-
clear division, centromere, and others almost exclusively
related to cell cycle (Table 1, 24 h post IR). The individual
genes associated with the GO term ‘‘cell division’’ are
shown in Figure 4M. GSEA also identified primarily cell-cy-
cle-related categories as attenuated in HSCs with dmPGE2
(Table S2; Figures 4N and 4O). IPA predicted that dmPGE2
also increased cellular functions related to homeostasis
and hematopoietic capacity relative to vehicle at 24 h,
while attenuating DNA replication/repair-related activity
(Table 3). Overall, dmPGE2 preserved HSC homeostasis
genes and prevented the increase in cell-cycle genes by
24 h post IR, supporting the dmPGE2-mediated inhibition
of HSC cycling observed by flow cytometry at 24 h post IR
and in the non-IR setting (Figures 2A and 2B).DISCUSSION
Understanding tissue-specific radioprotective mechanisms
is important for the development of therapies for inten-
tional or accidental radiation exposures and for protection
during future endeavors beyond the earth’s protectivemag-
netic field. In this study, we performed phenotypic, func-
tional, and genomic analyses of primitive hematopoietic
cells with and without dmPGE2 radioprotection in aVID Functional Annotation analysis) from the 1-h RNA-seq (Table 1).
eh-IR versus Veh-NI at 1 h (Table S1). NES, normalized enrichment
53 class mediator’’ in PGE-IR versus Veh-IR at 1 h (Table S1).
ated with dmPGE2 in HSCs at 1 h post IR. Color intensity, prediction
e of gene set overlap.
p < 0.01.
genes at 1 h contributing to predictions in (F).
Cs 1 h post IR; n = 3 mice combined/group. (I) PCA plot of a single
eh-IR versus Veh-NI and Veh-IR versus PGE-IR by Kruskal-Wallis test
ative of three experiments.
division’’ (DAVID Functional Annotation analysis) (Table 1).
ome segregation’’ and (O) GO term ‘‘cell division’’ (Table S2).
Table 1. Top 10 Functional Annotation Enrichments among Genes Increased by Irradiation >2-Fold and Attenuated with dmPGE2
Term Category Term ID Count Fold Enrichment Benjamini p Value
1 h Post IR
p53 signaling pathway KEGG_PATHWAY mmu04115 12 19 1.7 3 109
Apoptosis UP_KEYWORDS NA 20 6 7.3 3 108
apoptotic process GOTERM_BP_DIRECT GO:0006915 23 6 1.3 3 107
TNF signaling pathway KEGG_PATHWAY mmu04668 12 12 1.9 3 107
NF-kB signaling pathway KEGG_PATHWAY mmu04064 11 12 5.6 3 107
inflammatory response GOTERM_BP_DIRECT GO:0006954 16 6 1.5 3 105
Epstein-Barr virus infection KEGG_PATHWAY mmu05169 12 6 1.0 3 104
NIK/NF-kB signaling GOTERM_BP_DIRECT GO:0038061 4 110 6.7 3 104
I-kB kinase/NF-kB signaling GOTERM_BP_DIRECT GO:0007249 6 26 6.9 3 104
response to cytokine GOTERM_BP_DIRECT GO:0034097 8 14 7.1 3 104
24 h Post IR
Mitosis UP_KEYWORDS NA 43 23 3.0 3 1043
Cell division UP_KEYWORDS NA 47 18 2.3 3 1042
Cell cycle UP_KEYWORDS NA 54 12 8.0 3 1041
Mitotic nuclear division GOTERM_BP_DIRECT GO:0007067 44 20 8.2 3 1041
Cell division GOTERM_BP_DIRECT GO:0051301 46 15 4.4 3 1038
Cell cycle GOTERM_BP_DIRECT GO:0007049 51 10 1.5 3 1034
Centromere UP_KEYWORDS NA 25 26 1.6 3 1025
Kinetochore GOTERM_CC_DIRECT GO:0000776 25 26 5.1 3 1025
Chromosome, centromeric region GOTERM_CC_DIRECT GO:0000775 25 22 1.6 3 1023
Cytoskeleton UP_KEYWORDS NA 48 6 2.7 3 1023
Top 10 enrichments assessed by DAVID bioinformatics tool.
All genes FDR < 0.05 for both increase with Veh-IR versus Veh-NI and decrease with PGE-IR versus Veh-IR; 155 genes at 1 h, 164 genes at 24 h.controlled murine model of H-ARS (Plett et al., 2012). Our
findings provide a prospective analysis of stem cells with
differing capacities to survive radiation exposure and repre-
sent the first study with this approach in HSCs.We confirm
that treatment with dmPGE2 before lethal IR increases sur-
vival (Steel et al., 1988; Walden et al., 1987) and protects
hematopoiesis as previously described in the sublethal
setting (Hanson and Ainsworth, 1985; Walden et al.,
1987). We present a detailed evaluation of the effects of
dmPGE2 on primitive hematopoietic cells and its potential
mechanisms of action.
Lethal IR results in a significant increase in HSC prolifer-
ation by 24 h, accompanied by an increase in DNA DSB be-
tween 1 h and 24 h post IR. dmPGE2 given prior to IR atten-
uated both IR-induced cycling and DNA damage in HSCs,
delayed apoptosis, and attenuated the progression of mito-chondrial compromise, mitochondrial ROS production,
and senescence in surviving cells. By transcriptomic anal-
ysis, dmPGE2 predominantly attenuated induction of
p53-associated apoptotic genes within 1 h of IR, and atten-
uated the increase in cell-cycle genes at 24 h. An integrated
model of dmPGE2 radioprotection in HSCs is proposed in
Figure S7.
HSC cell cycle/quiescence is held in delicate balance,
with low proliferation rates essential for maintenance and
self-renewal (Hao et al., 2016; Seita and Weissman, 2010).
However, HSCs are ‘‘poised’’ to rapidly enter the cell cycle
in response to stress (Cheung and Rando, 2013; Passegue
et al., 2005). Accordingly, rapid induction of HSC cycling
was observed within 24 h post IR. However, attempted
DNA replication immediately after IR exposure, before
repair of DNA lesions (Georgakilas et al., 2004; Sage andStem Cell Reports j Vol. 15 j 358–373 j August 11, 2020 367
Table 2. Top 10 Transcription Regulators with Predicted Activation in HSCs by dmPGE2 Alone
Symbol Name Z Score p Value No. of Genes
CREB1 cAMP responsive element binding protein 1 5.23 6.9 3 1013 59
STAT3 signal transducer and activator of transcription 3 3.44 2.9 3 1013 58
SMAD3 SMAD family member 3 3.38 1.9 3 105 23
CREM cAMP responsive element modulator 3.36 1.1 3 1016 33
NUPR1 nuclear protein 1 3.24 1.8 3 108 46
STAT6 signal transducer and activator of transcription 6 3.09 4.3 3 108 32
FOXL2 forkhead box L2 3.00 3.9 3 106 12
TP63 tumor protein p63 2.95 5.7 3 106 33
EGR1 early growth response 1 2.82 5.5 3 1013 31
TCF7L2 transcription factor 7 like 2 2.78 1.2 3 103 24
Predicted activation by Ingenuity Pathway upstream regulators analysis. Measured at 1.5 h post injection, no IR.Shikazono, 2017), can result in further DSB formation and
cell death (Staszewski et al., 2008). DNA damage increased
in HSCs over the first 24 h post IR, but both HSC cycling
and DNA DSB formation were attenuated by dmPGE2.
Maintenance of HSC quiescence by dmPGE2may be signif-
icant for protection, since the portion of HSCs in active cell
cycle is less capable of reconstitution upon transplant into
the lethally irradiated environment compared with those
in G0/G1 (Fleming et al., 1993). The observation that
dmPGE2 alone increases p21 and suppresses HSC/HPC
cycling within 1 h also raises the possibility that increased
quiescence prior to IR allows for less immediate DNA dam-
age. However, while NHEJ occurs in all cell-cycle phases, a
higher-fidelity DNA-repair mechanism (homologous
recombination) increases in cycling HSCs/HPCs exposed
to low-dose IR (Mohrin et al., 2010), suggesting that HSCs
irradiated while in cycle may have better quality of repair.
The extreme conditions of high-dose IRmay alter this para-
digm, but this merits further study in the context of
dmPGE2 radioprotection. Overall, cell-cycle suppression
by dmPGE2 likely plays a significant radioprotective role.
We reported that PGE2 inhibits proliferation of HPCs af-
ter in vivo administration (Gentile et al., 1983; Gentile and
Pelus, 1987). We now identify a temporary reduction in
HSC and HPC cycling for24 h following a single dmPGE2
dose, with a subsequent rebound in cycling above steady-
state levels by 48 h. Thus, differing PGE2 dosing regimens
and analysis time points may indicate either suppression
or activation of cycling. In addition, we and others have
shown that dmPGE2 increases HSC cycling following
short-pulse exposure in vitro (Hoggatt et al., 2009; North
et al., 2007; Pelus, 1982; Pelus and Hoggatt, 2011), illus-
trating that microenvironment is another important factor368 Stem Cell Reports j Vol. 15 j 358–373 j August 11, 2020for HSCs, and also for a pleiotropic bioactive lipid such as
dmPGE2. Regarding IR, we showed that dmPGE2 given
shortly after IR is radiomitigating, while an increase in
marrow PGE2 at later time points inhibits hematopoietic
regeneration (Hoggatt et al., 2013b). Together, these data
suggest that HSC and HPC cycling on the first day of IR
exposure is likely deleterious and is attenuated by dmPGE2,
while subsequent cycling is essential for regeneration, and
dmPGE2 given pre-IR may play a time-sensitive role.
P53 apoptotic signaling is well established in the cellular
IR response (Alvarez et al., 2006; Fei et al., 2002; Lee et al.,
2015). Apoptosis plays a central role in H-ARS post IR, and
p53 signaling is a known HSC response to genotoxic stress
(Shao et al., 2014; Yu et al., 2010). Interestingly, high p53
levels are maintained in HSCs at steady state and support
quiescence (Liu et al., 2009). This likely accounts for the
rapid induction of p53 activity in HSCs post IR, while its
quiescence function is likely overridden by hematopoietic
stress. Recent transcriptome analysis of primarily B-lineage
cells identified p53 signaling as themost enriched pathway
induced by IR, albeit at sublethal IR of 1–2 Gy, with
apoptosis as the most enriched GO category (Pawlik
et al., 2011). This p53 transcriptional response was
confirmed and extended in our study to lethal IR, and
expanded in depth for HSCs. RNA-seq analysis identified
161 total p53-regulated genes as significantly affected by
IR, the majority of which (107) were attenuated by
dmPGE2. Bbc3, also known as Puma (p53 upregulated
mediator of apoptosis), was one such gene upregulated in
HSC at 1 h and blocked by dmPGE2. Puma deletion in
mice confers striking survival from lethal IR, more so
than total p53 deletion, protecting HSCs from cell death
and functional compromise (Yu et al., 2010). Thus, Puma
Table 3. Cellular Functions 24 h Post IR Predicted Increased or Decreased in HSCs with dmPGE2
Functions Annotation Category Z Score Predicted Activation State p Value No. of Genes
Cellular homeostasis cellular function and maintenance 4.98 increased 2 3 1011 218
Hematopoiesis of mononuclear
leukocytes
hematopoiesis 4.54 increased 2 3 1014 122
Lymphopoiesis hematopoiesis 4.34 increased 9 3 1014 115
Homeostasis of leukocytes cellular function and maintenance 4.31 increased 2 3 1013 103
Cell movement cellular movement 4.28 increased 6 3 1023 327
Lymphocyte homeostasis cellular function and maintenance 4.07 increased 6 3 1012 98
Migration of cells cellular movement 4.02 increased 1 3 1022 298
T cell homeostasis hematological system development
and function
3.89 increased 7 3 1012 94
Microtubule dynamics cellular function and maintenance 3.76 increased 1 3 1011 174
Organization of cytoplasm cellular function and maintenance 3.76 increased 7 3 1014 221
Alignment of chromosomes DNA replication, recombination, and repair 2.67 decreased 8 3 1015 18
Metabolism of DNA DNA replication, recombination, and repair 2.16 decreased 5 3 1010 68
Repair of DNA DNA replication, recombination, and repair 2.12 decreased 2 3 1011 60
Predicted increase or decrease by Ingenuity Pathway diseases and functions analysis.
Showing top 10 predictions for ‘‘Increased’’ and all three predictions for ‘‘Decreased’’ in PGE-IR versus Veh-IR.suppression may be a major component of the dmPGE2
radioprotective mechanism.
It has been suggested that HSCs are uniquely more resis-
tant to IR-induced p53 activation through rapid induction
of p21 functioning to quench p53 phosphorylation by 6 h
post IR, at least in a sublethal setting (Insinga et al., 2013).
We also found that the lethal IR-induced p53 gene signa-
ture was early and transient in HSCs, strongly observable
at 1 h but dissipated by 24 h post IR, and IR alone
induced an 86-fold increase in p21 expression in HSCs by
1 h (FDR = 6.63 10168). However, dmPGE2 alone induced
a 17-fold increase in p21 in HSCs (FDR = 5.6 3 1081),
meaning it would already be elevated in HSCs at the time
of IR. Thus, rather than IR-induced p21 quickly reversing
the activation of p53 as described (Insinga et al., 2013),
dmPGE2-induced p21 expression pre-IR could be prevent-
ing the initial p53 activation.
Activation of CREB1 represents another potential molec-
ular mechanism of p53 attenuation in HSCs. PGE2
signaling stimulates cAMP, which binds to cAMP-depen-
dent protein kinase A (PKA), releasing its catalytic subunits
to activate nuclear CREB (Mayr and Montminy, 2001).
CREB1 had the highest Z score of activation in HSCs with
dmPGE2 alone. Activated CREB interacts with CREB bind-
ing protein (CBP) and its paralog p300 (CBP/p300) to facil-
itate transcription of its target genes. Intriguingly, bothCREB and p53, as well as NF-kB, are among multiple tran-
scription factors that must compete for binding to limiting
amounts of cellular CBP/p300 (Dyson and Wright, 2016;
Parry and Mackman, 1997). Thus, a limited supply of
CBP/p300 may be sequestered by CREB at the time of IR,
rendering it unavailable to p53 as well as NF-kB. Further
investigation of this mechanism could lead to novel radio-
protectants, since >400 proteins interact with CBP/p300
and provide competition for these limiting cofactors
(Bedford et al., 2010).
TNF⍺ production by bone marrow cells increases after IR
and induces hematopoietic cell apoptosis, while TNF
neutralization or knockout is protective (Cachaco et al.,
2010). Our findings support thismechanism inHSCs, iden-
tifying a strong gene signature of TNF activation and >2-
fold increase in marrow TNF⍺ concentration at 1 h post
IR. While dmPGE2 given prior to IR partially attenuated
the TNF gene signature, it did not inhibit the increase in
marrow TNF⍺. TNFR2 mRNA and surface expression was
significantly increased by dmPGE2 at the 1-h time point.
Unlike TNFR1, TNFR2 does not possess a ‘‘death domain’’
and is more associated with pro-survival signaling (Faust-
man and Davis, 2013; Naude et al., 2011). Furthermore,
TNFR2 is associated with protection from oxidative
stress (Fischer et al., 2011; Maier et al., 2013). These TNF
mechanisms remain to be explored, but it is likely thatStem Cell Reports j Vol. 15 j 358–373 j August 11, 2020 369
dmPGE2-induced upregulation of TNFR2 contributes to an
overall healthier HSC response to IR-induced TNF⍺. Inter-
estingly, in the non-IR context, HSCs possess a unique
TNF⍺ response that inhibits necroptosis while pushing
HSCs into cell cycle and myeloid regeneration (Yamashita
and Passegue, 2019). These anti-necroptosis signals abro-
gate toxicity of TNF⍺ itself but are likely inept against the
toxicity of lethal IR. However, the latter function raises
the possibility that TNF⍺ mediates the IR-induced HSC
cycling activation. By this model, alteration of TNF
signaling by dmPGE2 as observed here may link to its
cycling suppression of IR-damaged HSCs.
In summary, this study elucidates cellular and molecular
events occurring in HSCs during dmPGE2 radioprotection
from H-ARS. In particular, dmPGE2 appears to block initia-
tion of the p53-regulated apoptotic program in HSCs
within 1 h post IR and attenuates HSC entry into the cell
cycle within the first critical day post IR (Figure S7). These
functions appear to prevent excess HSC compromise and
preserve repopulating capacity early after IR, ultimately al-
lowing for hematopoietic recovery and survival from an
otherwise lethal IR exposure.EXPERIMENTAL PROCEDURES
Mice
Indiana University School of Medicine IACUC approved all
studies. SPF C57BL/6 (CD45.2) mice (Jackson Labs, Bar Harbor,
ME) were received at 10 weeks old, acclimated for 2 weeks, and
used at 12 weeks old. BoyJ (CD45.1) (B6.SJL-Ptprc) mice were
bred in the IUSCC In Vivo Therapeutics Core facility. Fgd5-ZsGreen
mice (C57BL/6N-Fgd5tm2Djr/J) were from Jackson and bred in-
house. Further information is provided in Supplemental Experi-
mental Procedures.
Irradiation
Mice were placed in single chambers of a Plexiglas IR device and
exposed to a uniform total body g-IR dose of 8.53 Gy for IR studies,
and 11-Gy split dose for transplant recipients 1 day prior to trans-
plant. Further information is available in Supplemental Experi-
mental Procedures.
dmPGE2
dmPGE2 inmethyl acetatewas fromCaymanChemicals (AnnArbor,
MI) andwas storedat20C.Prior touse,dmPGE2wasevaporated to
dryness on ice under N2 and reconstituted in 100%EtOH at 0.1mg/
mL. Mice received a single subcutaneous injection of 35 mg of
dmPGE2orEtOH(3.5%) in100mLof saline30minbefore irradiation.
Histology
Femurs were fixed overnight in 4% paraformaldehyde, decalcified
in 10% EDTA for 7 days, and paraffin-embedded. Five-micrometer
slices were stained with hematoxylin and eosin (H&E) as described
in Hoggatt et al. (2013a).370 Stem Cell Reports j Vol. 15 j 358–373 j August 11, 2020Flow Cytometry
Samples were analyzed with an LSRII flow cytometer (BD Biosci-
ences, San Jose, CA). Cell sortingwas performed on a BD SORPAria.
Cell Isolation and Staining
Bone marrow cells were stained with an amine-reactive live/dead
dye (Invitrogen LIVE/DEAD Fixable Dead Cell Stain kit; Thermo
Fisher, Waltham, MA) followed by antibodies to HSC markers for
gating Lineage, Sca-1+, c-Kit+, CD150+, and CD48. The pan-
WBC markers CD45, CD34, and Flt3 were included in some cases.
Further antibody and staining information is provided in Supple-
mental Experimental Procedures. Total HSCs/mouse was calcu-
lated bymultiplying pHSC frequency by TNC, andwas adjusted ac-
cording to the fraction of total marrow mass represented by the
utilized bones (Boggs, 1984).
Colony-Forming Cell Assay
CFCswere quantitated as described byHoggatt et al. (2013a). TNCs
from non-IR mice were plated at 2 3 104 per 35-mm dish in tripli-
cate in ColonyGEL Mouse Complete Medium (Reach Bio, Seattle,
WA). Cells from IR mice were plated at 0.5–1 3 106 per dish.
CFU-GEMM, CFU-GM, and BFU-E were scored microscopically af-
ter 7 days at 37C, 5% CO2, and 5% O2.
Bone Marrow Transplantation
Bone marrow cells from C57BL/6 mice (CD45.2) were admixed
with bone marrow cells from Boy/J mice (CD45.1) for competitive
transplant into lethally irradiated Boy/J mice. Further information
is provided in Supplemental Experimental Procedures.
Cell Cycle
Ten million bone marrow cells/mouse were stained for HSC
markers, fixed and permeabilized, and stained with either anti-
Ki-67 antibody and 1 mg/mL DAPI, or with pyronin Yand Hoechst
33342, as described by Chitteti and Srour (2014).
Mitochondrial Function
Bone marrow cells were stained for HSC markers. For mitochon-
drial ROS detection, cells were incubated with 100 nM Mito
DCFDA ROS (Molecular Probes) for 30min at 37C.Mitochondrial
membrane potential was analyzed following incubation with
100 nM tetramethylrhodamine ethyl ester in PBS (TMRE; Molecu-
lar Probes) for 20 min at 37C. To estimate mitochondrial mass,
100 nM Mito Tracker Green FM (Molecular Probes) was added
together with TMRE. The ratio of TMRE/Mito FM was used as the
final measure of mitochondrial membrane potential.
SA-b-Gal Staining
Senescence-associated b-galactosidase (SA-b-gal) was analyzed
using the FluoReporter lacZ Flow Cytometry Kit (Molecular
Probes) as directed. Bone marrow cells were stained for HSC
markers and suspended with lacZ staining medium at107 cells/
mL. One hundred microliters of pre-warmed 2 mM fluorescein
b-D-galactopyranoside was added to 100 mL of cells and placed in
a 37C water bath for 1 min. The reaction was stopped by adding
ice-cold staining medium and analyzed by flow cytometry.
ELISA
TNFa in bone marrow supernatants was quantitated by Mouse
TNFaHigh Sensitivity ELISA (Thermo Fisher). Further information
is available in Supplemental Experimental Procedures.
HSC Sorting and RNA Sequencing
Bone marrow from Fgd5 mice was lineage depleted (EasySep
Mouse Hematopoietic Progenitor Cell Isolation kit; STEMCELL
Technologies) and stained for HSC markers. Viable HSCs were
gated by SLAM-LSK and ZsGreen+ (Fgd5) and sorted into lysis
buffer for RNA extraction using the RNeasy PlusMicro Kit (Qiagen,
Hilden, Germany). Sequencing was performed using the Hi-
Seq4000 system (Illumina). Further information is provided in
Supplemental Experimental Procedures.
Quantitative PCR
Single-cell qRT-PCR was performed using the Fluidigm C1 and
Biomark systems (San Francisco, CA). Primer probes are shown in
Table S3. Further information is provided in Supplemental Experi-
mental Procedures.
Statistics
All data are shown asmean ± SEM. Student’s t tests were performed
for statistical analysis between two groups. One-way ANOVA with
Dunnett’s test was used to compare three or more groups, and to
compare two ormore groupswith a single control group. Statistical
analysis was performed using Microsoft Excel and GraphPad
Prism 8.
Data and Code Availability
The accession number for the RNA sequencing data generated in
this paper is GEO: GSE151799.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.07.004.
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